A.L. Messchendorp

E-mail:
a.l.messchendorp umcg.nl

Research

Publications
  1. Effect of a Somatostatin Analogue on the Vasopressin Pathway in Patients With ADPKD

    DIPAK-1 Study Investigators, Messchendorp, A. L., Kramers, B. J., Spithoven, E. M., Stade, K., Meijer, E. & Gansevoort, R. T., Aug-2019, In : Kidney International Reports. 4, 8, p. 1170-1174 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

    DIPAK Consortium Investigators, 27-Apr-2019, In : Nephrology, Dialysis, Transplantation. 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease

    DIPAK-1 Investigators, Aug-2019, In : Gastroenterology. 157, 2, p. 481-+ 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. ADPKD: Risk Prediction for Treatment Selection

    Messchendorp, A. L., 2019, [Groningen]: Rijksuniversiteit Groningen. 292 p.

    Research output: ThesisThesis fully internal (DIV)Academic

  5. Association of plasma somatostatin with disease severity and progression in patients with autosomal dominant polycystic kidney disease

    DIPAK Consortium, Messchendorp, A. L., Spithoven, E. M., Casteleijn, N. F., Dam, W. A., van den Born, J., Tonnis, W. F., Gaillard, C. A. J. M. & Meijer, E., 19-Dec-2018, In : Bmc nephrology. 19, 10 p., 368.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (20) »

View graph of relations

ID: 13574731